News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
68,380 Results
Type
Article (1916)
Company Profile (1)
Press Release (66463)
Section
Business (21461)
Career Advice (9)
Deals (4552)
Drug Development (8151)
FDA (1798)
Job Trends (799)
News (36982)
Policy (3561)
Tag
Academia (91)
Africa (78)
Alliances (8078)
Alzheimer's disease (107)
Approvals (1800)
Artificial intelligence (2)
Asia (20953)
Australia (2400)
Bankruptcy (8)
Best Places to Work (566)
Biosimilars (6)
Biotechnology (5)
Breast cancer (5)
C2C Services and Suppliers (6403)
California (123)
Canada (111)
Cancer (53)
Career advice (9)
Cell therapy (4)
China (42)
Clinical research (6783)
Collaboration (15)
Connecticut (3)
COVID-19 (174)
Data (44)
Diabetes (5)
Diagnostics (572)
Drug discovery (3)
Duchenne muscular dystrophy (5)
Earnings (7392)
Europe (12122)
Events (6730)
Executive appointments (11)
FDA (1835)
Florida (6)
Funding (13)
GLP-1 (32)
Government (233)
Healthcare (1066)
Hotbed/Location (30027)
Illinois (6)
India (4)
Infectious disease (175)
Inflammatory bowel disease (13)
IPO (1594)
Japan (11)
Job creations (240)
Job search strategy (9)
Kansas (5)
Layoffs (5)
Legal (941)
Liver cancer (14)
Lung cancer (11)
Maine (4)
Manufacturing (5)
Maryland (46)
Massachusetts (92)
Medical device (1095)
Medtech (1096)
Mergers & acquisitions (2974)
Metabolic disorders (12)
Minnesota (18)
Neuroscience (119)
New Jersey (46)
New York (58)
NextGen Class of 2024 (218)
Non-profit (61)
North Carolina (38)
Northern California (69)
Obesity (4)
Pancreatic cancer (3)
Parkinson's disease (5)
Patents (6)
Pennsylvania (18)
People (4878)
Phase I (1833)
Phase II (2827)
Phase III (2585)
Pipeline (17)
Postmarket research (241)
Preclinical (637)
Radiopharmaceuticals (21)
Rare diseases (8)
Real estate (599)
Regulatory (2483)
Reports (6)
Research institute (91)
Schizophrenia (3)
Series A (4)
South America (104)
Southern California (40)
Startups (421)
Supply chain (3)
Texas (5)
United States (488)
Utah (4)
Vaccines (9)
Venture capitalists (2)
Virginia (4)
Wisconsin (3)
Date
Last 7 days (57)
Last 30 days (209)
Last 365 days (3504)
2024 (2524)
2023 (3814)
2022 (7013)
2021 (6372)
2020 (5872)
2019 (3867)
2018 (3013)
2017 (3562)
2016 (3176)
2015 (4030)
2014 (3020)
2013 (2604)
2012 (2775)
2011 (2903)
2010 (2663)
68,380 Results for "evogene ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Evogene Reports First Quarter 2024 Financial Results
Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize the development of life-science-based products, today announced its financial results for the first quarter period ended March 31, 2024.
May 23, 2024
·
18 min read
Business
Evogene Schedules First Quarter 2024 Financial Results Release
Evogene Ltd., a leading computational biology company targeting to revolutionize life-science product discovery and development, announced that it will release its financial results for the first quarter of 2024, on Thursday, May 23, 2024.
May 9, 2024
·
2 min read
Business
Evogene Reports Fourth Quarter and Full Year 2023 Financial Results
Evogene Ltd. today announced its financial results for the fourth quarter and full-year period ending December 31, 2023.
March 7, 2024
·
19 min read
Business
Evogene Schedules Fourth Quarter 2023 Financial Results Release & Conference Call for March 7th, 2024
Evogene Ltd announced today that it will release its financial results for the third quarter of 2023 on Thursday, March 7th, 2024.
February 26, 2024
·
2 min read
Evogene Reports Receipt of Nasdaq Minimum Bid Price Notification - March 20, 2024
Evogene Ltd. reported that the Company received a letter from the Nasdaq Stock Market LLC, indicating that the Company is currently not in compliance with Nasdaq Rule 5550, as the Company’s closing bid price for its ordinary shares has been below $1.00 per share for the last 30 consecutive business days.
March 20, 2024
·
5 min read
Business
Evogene Reports Third Quarter 2023 Financial Results
Evogene Ltd today announced its financial results for the third quarter period ended September 30, 2023.
November 15, 2023
·
18 min read
Business
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
Evogene Ltd. announced that it will release its financial results for the third quarter of 2023, on Wednesday, November 15, 2023.
November 2, 2023
·
2 min read
Business
Evogene Reports Second Quarter 2023 Financial Results
Evogene Ltd. today announced its financial results for the second quarter period ended June 30, 2023.
August 17, 2023
·
18 min read
Drug Development
Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma
Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd., announced encouraging initial findings from an ongoing Phase 1 clinical trial.
May 23, 2024
·
9 min read
Business
Evogene Schedules Second Quarter 2023 Financial Results Release & Conference Call for August 17, 2023
Evogene Ltd announced today that it will release its financial results for the second quarter of 2023, on Thursday, August 17, 2023.
August 1, 2023
·
2 min read
1 of 6,838
Next
